Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial

Abstract This study aimed to provide insights into the relationship between lipid levels and new-onset diabetes (NOD) in 14,864 Chinese hypertensive patients without diabetes (6056 men and 8808 women) aged 45–75 years from the China Stroke Primary Prevention Trial (CSPPT, led by Nanfang Hospital, Gu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leliang Li, Ping Li, Juan Yang, Xiao Huang, Huihui Bao, Chunyan Zhang, Yun Song, Min Zhao, Meng Ji, Yi Wang, Geng Qian, Genfu Tang, Shanqun Jiang, Qiang Dong, Yan Zhang, Jianping Li, Xiping Xu, Binyan Wang, Yong Huo, Xiaoshu Cheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3699b55f7c0e4c04a0a0aafc8c44f589
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3699b55f7c0e4c04a0a0aafc8c44f589
record_format dspace
spelling oai:doaj.org-article:3699b55f7c0e4c04a0a0aafc8c44f5892021-12-02T15:05:29ZLipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial10.1038/s41598-017-07355-w2045-2322https://doaj.org/article/3699b55f7c0e4c04a0a0aafc8c44f5892017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07355-whttps://doaj.org/toc/2045-2322Abstract This study aimed to provide insights into the relationship between lipid levels and new-onset diabetes (NOD) in 14,864 Chinese hypertensive patients without diabetes (6056 men and 8808 women) aged 45–75 years from the China Stroke Primary Prevention Trial (CSPPT, led by Nanfang Hospital, Guangzhou, China). NOD (defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L at the end of study or self-reported physician diagnosis of diabetes or self-reported use of hypoglycemic agents during follow-up) was analyzed using multivariate analysis. Follow-up was censored on August 24, 2014. Among the 14,864 subjects, 1615 developed NOD (10.9%, men = 10.8% and women = 10.9%). Increased triglycerides (TG) [odds ratio (OR) = 1.18; 95% confidence interval (CI): 1.13–1.25, P < 0.001], TG/HDL (OR = 1.12; 95%CI: 1.08–1.17, P < 0.001), and decreased high density lipoprotein (HDL) (OR = 0.79; 95%CI: 0.67–0.93, P = 0.005) were associated with NOD, independently from age, gender, body mass index, clinical center, systolic blood pressure, diastolic blood pressure, FPG, smoking, and drinking. Compared to subjects with the methylenetetrahydrofolate reductase (MTHFR) 677 CC and TT genotypes, those with the CT genotype had a higher risk of NOD (OR = 1.54; 95%CI: 1.30–1.81, P for interaction = 0.044) in subjects with high TG. These results suggested that TG and TG/HDL were independent risk factors for NOD in this Chinese hypertensive population. HDL was a protective factor for NOD.Leliang LiPing LiJuan YangXiao HuangHuihui BaoChunyan ZhangYun SongMin ZhaoMeng JiYi WangGeng QianGenfu TangShanqun JiangQiang DongYan ZhangJianping LiXiping XuBinyan WangYong HuoXiaoshu ChengNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Leliang Li
Ping Li
Juan Yang
Xiao Huang
Huihui Bao
Chunyan Zhang
Yun Song
Min Zhao
Meng Ji
Yi Wang
Geng Qian
Genfu Tang
Shanqun Jiang
Qiang Dong
Yan Zhang
Jianping Li
Xiping Xu
Binyan Wang
Yong Huo
Xiaoshu Cheng
Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
description Abstract This study aimed to provide insights into the relationship between lipid levels and new-onset diabetes (NOD) in 14,864 Chinese hypertensive patients without diabetes (6056 men and 8808 women) aged 45–75 years from the China Stroke Primary Prevention Trial (CSPPT, led by Nanfang Hospital, Guangzhou, China). NOD (defined as fasting plasma glucose (FPG) ≥ 7.0 mmol/L at the end of study or self-reported physician diagnosis of diabetes or self-reported use of hypoglycemic agents during follow-up) was analyzed using multivariate analysis. Follow-up was censored on August 24, 2014. Among the 14,864 subjects, 1615 developed NOD (10.9%, men = 10.8% and women = 10.9%). Increased triglycerides (TG) [odds ratio (OR) = 1.18; 95% confidence interval (CI): 1.13–1.25, P < 0.001], TG/HDL (OR = 1.12; 95%CI: 1.08–1.17, P < 0.001), and decreased high density lipoprotein (HDL) (OR = 0.79; 95%CI: 0.67–0.93, P = 0.005) were associated with NOD, independently from age, gender, body mass index, clinical center, systolic blood pressure, diastolic blood pressure, FPG, smoking, and drinking. Compared to subjects with the methylenetetrahydrofolate reductase (MTHFR) 677 CC and TT genotypes, those with the CT genotype had a higher risk of NOD (OR = 1.54; 95%CI: 1.30–1.81, P for interaction = 0.044) in subjects with high TG. These results suggested that TG and TG/HDL were independent risk factors for NOD in this Chinese hypertensive population. HDL was a protective factor for NOD.
format article
author Leliang Li
Ping Li
Juan Yang
Xiao Huang
Huihui Bao
Chunyan Zhang
Yun Song
Min Zhao
Meng Ji
Yi Wang
Geng Qian
Genfu Tang
Shanqun Jiang
Qiang Dong
Yan Zhang
Jianping Li
Xiping Xu
Binyan Wang
Yong Huo
Xiaoshu Cheng
author_facet Leliang Li
Ping Li
Juan Yang
Xiao Huang
Huihui Bao
Chunyan Zhang
Yun Song
Min Zhao
Meng Ji
Yi Wang
Geng Qian
Genfu Tang
Shanqun Jiang
Qiang Dong
Yan Zhang
Jianping Li
Xiping Xu
Binyan Wang
Yong Huo
Xiaoshu Cheng
author_sort Leliang Li
title Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
title_short Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
title_full Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
title_fullStr Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
title_full_unstemmed Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial
title_sort lipid levels and new-onset diabetes in a hypertensive population: the china stroke primary prevention trial
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3699b55f7c0e4c04a0a0aafc8c44f589
work_keys_str_mv AT leliangli lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT pingli lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT juanyang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT xiaohuang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT huihuibao lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT chunyanzhang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT yunsong lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT minzhao lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT mengji lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT yiwang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT gengqian lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT genfutang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT shanqunjiang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT qiangdong lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT yanzhang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT jianpingli lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT xipingxu lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT binyanwang lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT yonghuo lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
AT xiaoshucheng lipidlevelsandnewonsetdiabetesinahypertensivepopulationthechinastrokeprimarypreventiontrial
_version_ 1718388821679144960